For African Americans Living with Multiple Myeloma. Is a Clinical Trial Right for Me? 7 Useful Things You Should Know

Y our participation matters because... African Americans are under-represented in cancer clinical trials, including multiple myeloma trials. Notes from the doctor... Notes 2 African Am ericans are under-represented in clinical trials For African Americans with multiple myeloma, your participation helps doctors and scientists understand differences among patients and address ways to improve care . • Diversity in clinical trials is important. For example, if African Americans are under-represented in a multiple myeloma study, there is a risk that the results may not apply to African Americans as they do for other patients included in the study. Currently, less than 1 in 10 (only 8.6%) African American patients are represented in multiple myeloma clinical trials. • Clinical trials also help spread the impact of care across populations. Studies have shown that African Americans have done as well or better than white Americans in clinical trials when getting the same access to care. • Ultimately, your participation in a clinical trial will help scientists evaluate new multiple myeloma treatments and determine whether they are e ective and safe, and help doctors understand if the new medication improves the current standard of care. WHITE ASIAN OTHER HISPANIC AFRICAN AMERICAN PARTICIPANTS IN MULTIPLE MYELOMA CLINICAL TRIALS Que stions for the doctor... 7 3 1 5 otes 4 6 7